Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CVTX - CV Therapeutics, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: mopgcw who wrote (47)	10/15/2002 10:14:32 PM
From: mopgcw	Read Replies (1) \| Respond to of 411

Cardiovascular Drug Discovery&Development Summit to Feature Next Generation Therapeutics on February 10&11 in San Diego, CA PR Newswire, Tuesday, October 15, 2002 at 08:46 SAN DIEGO, Oct 15, 2002 /PRNewswire via COMTEX/ -- The cardiovascular research field will convene to discuss the latest efforts in drug discovery and clinical development for the next generation of therapeutics at the first-ever,"Cardiovascular Drug Discovery&Development Summit,"which will take place in San Diego, CA on February 10&11, 2003, announces Strategic Research Institute. Highlights of the meeting include: --"Clinical Development of Crestor,"by AstraZeneca --"Nuclear Receptor PPAR in Macrophages Results in Reduced Inflammatory Response and Atherosclerotic Lesion,"by The Salk Institute --"Inhibition of ApoB-100 with Antisense Technology as a Therapeutic Strategy for the Treatment of Hyperlipidemias,"Isis Pharmaceuticals List of presenters include: AstraZeneca, Bristol-Myers Squibb, Eli Lilly&Co., Millennium Pharmaceuticals, Pharmacia Corporation, Procter&Gamble Pharmaceuticals, Atherogenics, Collateral Therapeutics, CV Therapeutics, Isis Pharmaceuticals, Myogen, Sequenom, Texas Biotechnology, Purdue University, Salk Institute, Scripps Research Institute, and Southwestern Medical Center. To receive the full agenda and/or register for the conference, please contact Jon E. Liong of Strategic Research Institute at jliong@srinstitute.com or 212-967-0095, x243 (please include name, corporate affiliation, mailing address, and fax number). For information on exposition, or to sponsor a function please contact Mark Alexay at malexay@srinstitute.com.